Speaker Credentials
MS-II
Speaker Credentials
MS
College
College of Allopathic Medicine
Medical Specialty
Dermatology
Format
Poster
Start Date
November 2024
End Date
November 2024
Track
4
Abstract
Introduction: Subcutaneous Lupus Erythematous (SCLE), a cutaneous form of Lupus Erythematous (LE), is an autoimmune disease which manifests as a chronic skin condition that may or may not include systemic involvement. SCLE occurs in every 4 people per 100,000, which has remained a consistent occurrencerate over the past 40 years. Currently, first line therapy for the skin manifestations of LE are topical and systemic steroids, which pose a risk of long-term side effects. Herein, we suggest a series of Intense Pulse Light (IPL) sessions as a treatment optionfor the malar rash associated with SCLE to improve the appearance of the associated erythema. Case Presentation: Patient is a65 year old male presenting with erythema on his face and arms. He had a previous history of a positive ANA test, but tests for systemic LE were negative. He had exhausted multiple topical and systemic therapies including topical steroids, corticosteroids, antimalarials, methotrexate, and immunomodulators with little to no improvement. After a biopsy was performed confirming SCLE, IPL was presented to the patient as an alternative treatment option to pharmaceutical therapy. Patient agreed and received a series of 13 consecutive IPL treatments performed monthly. Outcome: After IPL treatments, improvement was significant,and he was able to discontinue systemic corticosteroid medications without flaring. The patient has not experienced any flares in the past two years while receiving maintenance IPL treatments three times per year. Discussion: At present, there is minimal data published on the use of IPL as a treatment option for the clinical presentation of an SCLE malar rash. Pharmaceutical intervention has been the gold standard of treatment for all manifestations of LE. However, patients without systemic involvement continue to expose themselves to the risk of serious adverse effects in hopes of improving their appearance. The present case suggests IPL as a safer alternative to current gold-standard therapies.
Included in
Using Intense Pulse Light to Treat Facial Erythema Associated With Subcutaneous Lupus Erythematous: A Case Report
Introduction: Subcutaneous Lupus Erythematous (SCLE), a cutaneous form of Lupus Erythematous (LE), is an autoimmune disease which manifests as a chronic skin condition that may or may not include systemic involvement. SCLE occurs in every 4 people per 100,000, which has remained a consistent occurrencerate over the past 40 years. Currently, first line therapy for the skin manifestations of LE are topical and systemic steroids, which pose a risk of long-term side effects. Herein, we suggest a series of Intense Pulse Light (IPL) sessions as a treatment optionfor the malar rash associated with SCLE to improve the appearance of the associated erythema. Case Presentation: Patient is a65 year old male presenting with erythema on his face and arms. He had a previous history of a positive ANA test, but tests for systemic LE were negative. He had exhausted multiple topical and systemic therapies including topical steroids, corticosteroids, antimalarials, methotrexate, and immunomodulators with little to no improvement. After a biopsy was performed confirming SCLE, IPL was presented to the patient as an alternative treatment option to pharmaceutical therapy. Patient agreed and received a series of 13 consecutive IPL treatments performed monthly. Outcome: After IPL treatments, improvement was significant,and he was able to discontinue systemic corticosteroid medications without flaring. The patient has not experienced any flares in the past two years while receiving maintenance IPL treatments three times per year. Discussion: At present, there is minimal data published on the use of IPL as a treatment option for the clinical presentation of an SCLE malar rash. Pharmaceutical intervention has been the gold standard of treatment for all manifestations of LE. However, patients without systemic involvement continue to expose themselves to the risk of serious adverse effects in hopes of improving their appearance. The present case suggests IPL as a safer alternative to current gold-standard therapies.